Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica · 2024
Salvage cryotherapy for prostate cancer.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
E Brito Duarte Vieira, Pereira Jose Alberto, Ferreira Ana Maria, Lourenço Mario, Godinho Ricardo, Pereira Bruno, Peralta Pedro, Conceiçao Paulo, Reis Mario, Rabaça Carlos
Аннотация
BACKGROUND: Most men diagnosed with prostate cancer will be candidates for active treatment and 20 to 50% of patients treated with organ preserving strategies recur within the prostate. Optimal treatment of recurrence is controversial. Prostate cryosurgery has been increasingly used as primary, recurrence and focal treatment for prostate cancer.
METHODS: We analysed 55 patients submitted to cryotherapy as salvage treatment after recurrence.
RESULTS: Study population presented with a mean age of 70.9 ± 6.2 years, mean initial PSA of 7.6 ng/ml and average prostate volume by ultrasound of 43.2 ± 14.7 grams. Mean follow-up was of 18.0 months. Biochemical free survival at one year of follow-up was of 85%.
CONCLUSIONS: Cryotherapy can be an effective and safe treatment for recurrence after primary curative treatment failure.
METHODS: We analysed 55 patients submitted to cryotherapy as salvage treatment after recurrence.
RESULTS: Study population presented with a mean age of 70.9 ± 6.2 years, mean initial PSA of 7.6 ng/ml and average prostate volume by ultrasound of 43.2 ± 14.7 grams. Mean follow-up was of 18.0 months. Biochemical free survival at one year of follow-up was of 85%.
CONCLUSIONS: Cryotherapy can be an effective and safe treatment for recurrence after primary curative treatment failure.